In PDAC research, CD24 was successfully implemented as one of the stem cell markers (along with CD44 and ESA) in the first animal studies of stemness in pancreatic ductal adenocarcinoma [16]. This evidence concerns the gene CD44 and pancreatic ductal adenocarcinoma.